Cargando…
Serial Lipocalin 2 and Oncostatin M levels reflect inflammation status and treatment response in axial spondyloarthritis
BACKGROUND: Informative serum biomarkers for monitoring inflammatory activity and treatment responses in axial spondyloarthritis (axSpA) are lacking. We assessed whether Lipocalin 2 (LCN2) and Oncostatin M (OSM), both having roles in inflammation and bone remodeling, may accurately reflect chronic j...
Autores principales: | Tsui, Florence W. L., Lin, Aifeng, Sari, Ismail, Zhang, Zhenbo, Tsui, Hing Wo, Inman, Robert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120829/ https://www.ncbi.nlm.nih.gov/pubmed/33990221 http://dx.doi.org/10.1186/s13075-021-02521-y |
Ejemplares similares
-
Lipocalin 2 links inflammation and ankylosis in the clinical overlap of inflammatory bowel disease (IBD) and ankylosing spondylitis (AS)
por: Lin, Aifeng, et al.
Publicado: (2020) -
The role of LCN2 and LCN2-MMP9 in spondylitis radiographic development: gender and HLA-B27 status differences
por: Tsui, Florence W. L., et al.
Publicado: (2022) -
Aberrant axial mineralization precedes spinal ankylosis: a molecular imaging study in ank/ank mice
por: Las Heras, Facundo, et al.
Publicado: (2011) -
The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis
por: Tsui, Florence WL, et al.
Publicado: (2014) -
Axial Spondyloarthritis: Current Advances, Future Challenges
por: Inman, Robert D
Publicado: (2021)